Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-TPMT Antibody (R1Y29)

Catalog #:   RHE83502 Specific References (36) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: FCM, IHC, WB
Accession: P51580
Overview

Catalog No.

RHE83502

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

FCM: 1:20-1:100, IHC: 1:100-1:200, WB: 1:1000-1:2000

Target

Thiopurine methyltransferase, Thiopurine S-methyltransferase, TPMT

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P51580

Applications

FCM, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1Y29

Data Image
  • Western blot
    Western blot analysis of TPMT expression in Jurkat cell lysate.
References

A Review of the Regulatory Challenges of Personalized Medicine., PMID:39328627

[Benefit of therapeutic drug monitoring of immunosuppressants and immunomodulators in the management of autoimmune diseases]., PMID:35643786

Modern developments in germline pharmacogenomics for oncology prescribing., PMID:35302652

Unusual Bilateral Upper Extremity Pitting Edema in a Patient With Severe Dermatomyositis., PMID:34113527

Genetic Factors of Predisposition and Clinical Characteristics of Rheumatoid Arthritis in Russian Patients., PMID:34070522

Tests that now deserve to be more widely adopted in IBD clinical practice., PMID:32782481

NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease., PMID:32482022

Key insights from therapeutic drug monitoring in Crohn's disease patients., PMID:30892105

New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease., PMID:30845128

Systematic Review: Cost-effective Strategies of Optimizing Anti-tumor Necrosis and Immunomodulators in Inflammatory Bowel Disease., PMID:30689858

Azathioprine Hypersensitivity Syndrome in a Cohort of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients., PMID:30368003

Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis., PMID:29752633

Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort study., PMID:29630648

Relationship between Azathioprine metabolites and therapeutic efficacy in Chinese patients with neuromyelitis optica spectrum disorders., PMID:28679367

Role of Allopurinol in Optimizing Thiopurine Therapy in Patients with Autoimmune Hepatitis: A Review., PMID:28348471

Genotypes Affecting the Pharmacokinetics of Anticancer Drugs., PMID:27641154

Human genome meeting 2016 : Houston, TX, USA. 28 February - 2 March 2016., PMID:27294413

Pharmacogenetics of inflammatory bowel disease., PMID:25521361

The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients., PMID:23932783

My treatment approach to the management of ulcerative colitis., PMID:23910410

Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease., PMID:22741564

Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia., PMID:22484422

How are thiopurines used and monitored by Swedish gastroenterologists when treating patients with inflammatory bowel disease?, PMID:21793634

Conventional treatment in inflammatory bowel disease--recent trends. Immunosuppressants and biologic agents: should they or need they be used together? How to use immunosuppressive therapy better (and safer) tomorrow?, PMID:20117343

Variation in care in pediatric Crohn disease., PMID:19590456

Thiopurinemethyltransferase (TPMT) genotype and TPMT activity in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: relation to azathioprine maintenance treatment and adverse effects., PMID:19366895

Dual-allele dipstick assay for genotyping single nucleotide polymorphisms by primer extension reaction., PMID:18685560

Pharmacogenetics of Crohn's disease., PMID:18597652

Pharmacogenetics in inflammatory bowel disease., PMID:16773681

Genetic testing in Crohn disease: utility in individualizing patient management., PMID:16078858

Pharmacogenetics of inflammatory bowel disease., PMID:15669633

Advances in medical therapy for Crohn's disease., PMID:12441041

Mucosal protection against sulphide: importance of the enzyme rhodanese., PMID:11788560

Pharmacokinetic considerations in the treatment of inflammatory bowel disease., PMID:11707060

Thiopurine methyltransferase regulation in rat kidney: immunoprecipitation studies., PMID:1897245

Mouse thiopurine methyltransferase pharmacogenetics: correlation of immunoreactive protein and enzymatic activity., PMID:2313588

Datasheet

Document Download

Anti-TPMT Antibody (R1Y29).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-TPMT Antibody (R1Y29) [RHE83502]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only